Carole Huntsman serves as Executive at MADRIGAL PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Carole Huntsman has executed 13 insider transactions totaling $1.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 21, 2025 involved selling 40 shares valued at $22.1K.
Carole Huntsman currently holds 10,552 shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carole Huntsman has been a net seller of MDGL stock. They have purchased $0 and sold $1.1M worth of shares.
Carole Huntsman's most recent insider trade was on Nov 21, 2025, when they sold 40 shares at $553.23 per share.
Get notified when new Form 4 filings are submitted
| $550.97 |
| Discretionary |
| Nov 21, 2025 | MDGL | $45.2K | Sale | 80 | $564.57 | Discretionary |
| Nov 21, 2025 | MDGL | $22.5K | Sale | 40 | $563.21 | Discretionary |
| Nov 21, 2025 | MDGL | $44.8K | Sale | 80 | $560.62 | Discretionary |
| Nov 21, 2025 | MDGL | $111.9K | Sale | 200 | $559.60 | Discretionary |
| Nov 21, 2025 | MDGL | $66.7K | Sale | 120 | $556.04 | Discretionary |
| Nov 21, 2025 | MDGL | $110.5K | Sale | 200 | $552.38 | Discretionary |
| Nov 21, 2025 | MDGL | $22.0K | Sale | 40 | $549.34 | Discretionary |
| Nov 21, 2025 | MDGL | $65.8K | Sale | 120 | $548.71 | Discretionary |
| Nov 21, 2025 | MDGL | $78.8K | Sale | 144 | $547.27 | Discretionary |
| Jan 23, 2024 | MDGL | $0 | Award | 3,639 | $N/A | Discretionary |
| Nov 20, 2023 | MDGL | $0 | Award | 7,834 | $N/A | Discretionary |